Scilex Holding (SCLX) Tax Provisions (2022 - 2025)
Scilex Holding (SCLX) posted quarterly Tax Provisions of $6000.0 for Q4 2025, up 700.0% year-over-year from $750.0 in Q4 2024, and up 500.0% on a QoQ basis from $1000.0 in Q3 2025.
Scilex Holding (SCLX) Tax Provisions (2022 - 2025) Analysis & Trends
Scilex Holding (SCLX) has reported Tax Provisions for 4 consecutive years, with $6000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Tax Provisions rose 700.0% year-over-year to $6000.0; the TTM figure through Dec 2025 stood at $25000.0 (up 2600.0% YoY), while the FY2025 annual figure was $26000.0, up 2700.0% from the prior year.
- Tax Provisions came in at $6000.0 for Q4 2025 at Scilex Holding, up from $1000.0 in the prior quarter.
- The five-year high for Tax Provisions was $40000.0 in Q4 2022, with the low at -$28000.0 in Q2 2022.
- Average Tax Provisions over 4 years is $3818.2, with a median of $3000.0 recorded in 2022.
- Across the five-year window, Tax Provisions sank 112.5% in 2024 and jumped 700.0% in 2025, its largest moves.
- Year by year, Tax Provisions stood at $40000.0 in 2022, then sank by 80.0% to $8000.0 in 2023, then tumbled by 112.5% to -$1000.0 in 2024, then surged by 700.0% to $6000.0 in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered $6000.0, $1000.0, and $19000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.45 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 755.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 342.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 3.08 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 709.00 Mn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 265.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 559.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 461.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -683.00 Mn |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Jun 30, 2023 | -3,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Dec 31, 2022 | 40,000.00 |
| Sep 30, 2022 | -11,000.00 |
| Jun 30, 2022 | -28,000.00 |
| Mar 31, 2022 | 3,000.00 |